Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service, Funding

From Entrance to Exit, Medical Alley Once Again Shows Its Strength as a Startup Ecosystem


Medical Alley Association released their mid-year report Monday, showing a strong first half for Medical Alley investment.

Medical Alley companies raised $261.6 million in the first half of the year, their second-best mark in the last five years, and signs are pointing to an active third quarter for angel- and seed-stage companies. The median raise in Q2 was $1.7 million, a five-year best for the second quarter. Merger and acquisition activity is also going strong in Medical Alley, with more than $15 billion spent in the second quarter alone.

Investors showed strong interest in companies focused on cardiovascular health, particularly those treating heart failure. Big data and health IT companies also drew strong interest from investors in the first two quarters.

Q2 did show a slight decrease in the number of companies raising money, due in part to companies and investors awaiting the reinstatement of the Angel Tax Credit Program, which was successfully revived during the 2019 Minnesota legislative session. The revival of this key program will likely result in an active third quarter with more companies raising funds, particularly at the lower dollar amounts.

With a strong first half in the books and concrete signs of strength at both ends of the startup spectrum, 2019 is shaping up to be another huge year for investable companies in Medical Alley.

To learn more and see the full report, visit Medical Alley Association here.

About the Medical Alley Association

Founded in 1984, the Medical Alley Association supports and advances the global leadership of Medical Alley's healthcare industry, and its connectivity around the world. MAA delivers the collective influence, intelligence and interactions that support Medical Alley.

www.medicalalley.org


These press releases may also interest you

at 15:05
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent directors Cristian Luput and Ramiro Guerrero, J.D, LL.M. made individual...

at 15:00
Beghou Consulting announced Thursday several additions to its executive team to support the company's technology innovation, product development and growth initiatives. Dan Cardinal, a Partner at Beghou, will become Chief Technology Officer. The...

at 15:00
Urban Wellness Group, a pioneering wellness provider, is proud to announce its official launch of new anti-aging and sleep enhancement treatments to southeast Portland. Dr. Jason Zabell and Dr. Andy Swanson set themselves apart by pairing over 30...

at 14:55
Peninsula Canada, a global leading HR and health & safety firm, committed to making a positive impact in the community, is proud to announce a partnership with SickKids Foundation, a leading charity dedicated to supporting The Hospital for Sick...

at 14:30
The "Global Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029" report has been added to  ResearchAndMarkets.com's offering. The Global Immunoprecipitation Testing Market size is estimated...

at 14:25
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...



News published on and distributed by: